ASLAN Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	85	114	-	-	-
Enterprise Value	-39	-52	-	-	-
Last Close Price	3.13	4.23	-	-	-
PB Ratio	0.69	0.75	-	-	-
P/TBV Ratio	0.69	0.75	-	-	-
Debt / Equity Ratio	0.20	0.11	0.14	0.28	-
Quick Ratio	18.16	16.81	14.71	8.76	15.17
Current Ratio	18.43	16.92	15.22	8.85	15.30
Return on Equity (ROE)	-42.79%	-55.19%	-67.95%	-88.40%	-
Return on Assets (ROA)	-24.72%	-32.46%	-34.38%	-45.81%	-
Return on Capital (ROIC)	-26.01%	-34.37%	-37.30%	-50.29%	-
Earnings Yield	-76.54%	-53.85%	-	-	-
FCF Yield	-66.82%	-43.39%	-	-	-
Buyback Yield / Dilution	-106.95%	-559.39%	-8.27%	-42.78%	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q